rs1319351179
|
FABP4;LOC101927118
|
Malignant neoplasm of breast
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
rs1054135
|
FABP4;LOC101927118
|
Triple-Negative Breast Carcinoma
|
|
0.010 |
GeneticVariation |
BEFREE |
Immunohistochemical staining of adipocytes adjacent to TNBC tissues showed that the expression level of FABP4 was statistically significantly lower in patients with the rs1054135-GG genotype and those in the disease-free group (P=0.0004 and P=0.0091, respectively).
|
26959740 |
2016 |
rs1054135
|
FABP4;LOC101927118
|
Triple Negative Breast Neoplasms
|
|
0.010 |
GeneticVariation |
BEFREE |
Immunohistochemical staining of adipocytes adjacent to TNBC tissues showed that the expression level of FABP4 was statistically significantly lower in patients with the rs1054135-GG genotype and those in the disease-free group (P=0.0004 and P=0.0091, respectively).
|
26959740 |
2016 |
rs1054135
|
FABP4;LOC101927118
|
Neoplasms
|
|
0.010 |
GeneticVariation |
BEFREE |
Notably, for individuals having the rs1054135 SNP with the AA/AG genotype, the magnitude of increased tumour recurrence risk for overweight patients (BMI≥25kg/m2) was significantly elevated (HR2.53; 95%CI: 1.06-6.03).
|
26959740 |
2016 |
rs1054135
|
FABP4;LOC101927118
|
Sleep Apnea, Obstructive
|
|
0.010 |
GeneticVariation |
BEFREE |
The presence of selective SNP (e.g., rs1054135) in the FABP4 gene may account for increased plasma FABP4 levels in the context of obesity and OSA in children.
|
21664182 |
2011 |
rs1054135
|
FABP4;LOC101927118
|
Obesity
|
|
0.010 |
GeneticVariation |
BEFREE |
The presence of selective SNP (e.g., rs1054135) in the FABP4 gene may account for increased plasma FABP4 levels in the context of obesity and OSA in children.
|
21664182 |
2011 |
rs16909220
|
FABP4;LOC101927118
|
Polycystic Ovary Syndrome
|
|
0.010 |
GeneticVariation |
BEFREE |
Three polymorphisms, rs16909225, rs3834363, and rs16909220, were identified, of which rs16909225 and rs16909220 were completely linked (r² = 1) and not associated with the development of PCOS, while the -2-bp/-2-bp genotype of rs3834363 was significantly higher in PCOS than in the controls (χ² = 7.39, df = 1, P = 0.007, OR = 1.80 95% CI: 1.18-2.75).
|
19844814 |
2009 |
rs16909225
|
FABP4;LOC101927118
|
Polycystic Ovary Syndrome
|
|
0.010 |
GeneticVariation |
BEFREE |
Three polymorphisms, rs16909225, rs3834363, and rs16909220, were identified, of which rs16909225 and rs16909220 were completely linked (r² = 1) and not associated with the development of PCOS, while the -2-bp/-2-bp genotype of rs3834363 was significantly higher in PCOS than in the controls (χ² = 7.39, df = 1, P = 0.007, OR = 1.80 95% CI: 1.18-2.75).
|
19844814 |
2009 |
rs3834363
|
FABP4;LOC101927118
|
Polycystic Ovary Syndrome
|
|
0.010 |
GeneticVariation |
BEFREE |
Three polymorphisms, rs16909225, rs3834363, and rs16909220, were identified, of which rs16909225 and rs16909220 were completely linked (r² = 1) and not associated with the development of PCOS, while the -2-bp/-2-bp genotype of rs3834363 was significantly higher in PCOS than in the controls (χ² = 7.39, df = 1, P = 0.007, OR = 1.80 95% CI: 1.18-2.75).
|
19844814 |
2009 |